Pregled bibliografske jedinice broj: 598192
Use of urinary protein:creatinine ratio in advanced stages of chronic kidney disease in diabetes
Use of urinary protein:creatinine ratio in advanced stages of chronic kidney disease in diabetes // Biochemia Medica / Šimundić, Ana-Maria (ur.).
Zagreb: Hrvatsko društvo za medicinsku biokemiju i laboratorijsku medicinu (HDMBLM), 2012. str. A93-A93 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 598192 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Use of urinary protein:creatinine ratio in advanced stages of chronic kidney disease in diabetes
Autori
Radišić Biljak, Vanja ; Božičević, Sandra ; Pavković, Pajica ; Vučić Lovrenčić, Marijana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Biochemia Medica
/ Šimundić, Ana-Maria - Zagreb : Hrvatsko društvo za medicinsku biokemiju i laboratorijsku medicinu (HDMBLM), 2012, A93-A93
Skup
2nd European Joint Congress of EFLM and UEMS and 7th Congress of the Croatian Society for Medical Biochemistry and Laboratory medicine (CSMBLM): Laboratory Medicine at the Clinical Interface.
Mjesto i datum
Dubrovnik, Hrvatska, 10.10.2012. - 13.10.2012
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
protein; creatinine; urine; diabetic nephropathy
Sažetak
Background: Albumin:creatinine ratio (ACR) is the recommended method for the detection of incipient kidney disease in diabetic patients. However, protein daily excretion rate is used for the quantification and monitoring of proteinuria in more-advanced stages of chronic kidney disese. We wanted to determine whether measurement of protein:creatinine ratio (PCR) can be used as an alternative to protein excretion rate in detecting clinically significant proteinuria in diabetic patients. Materials and methods: 48 diabetic patients were included in the study. We measured ACR and PCR in random urine samples and protein contents in 24-h urine samples. All measurements were made on Olympus AU600. Urinary albumin was measured by immunoturbidimetric method, while urinary creatinine and protein were measured by the spectrophotometric Jaffe and pyrogallol red method, respectively. Clinically significant proteinuria was considered to be present with the ACR ≥ 30 mg/mmol which is approximately equivalent to PCR 50 mg/mmol. All results were analyzed with MedCalc 9.4.2.0. statistical software (MedCalc Software bvba, Mariakerke, Belgium). Results: ACR was ≥ 30 mg/mmol in 28/48 diabetic patients. Sensitivity was 100% and specificity was 95.0% for PCR as an indicator of clinically significant proteinuria at a cut-off value of 50 mg/mmol. Protein daily excretion rate as an indicator of clinically significant proteinuria gave lower values for sensitivity and specificity at the cut-off value of > 0.5g/24h ; they were 78, 6% and 85, 0% respectively. Conclusions: The protein:creatinine ratio performed better as an indicator of clinically significant proteinuria than the 24-urine collection method in diabetic patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
045-1191348-0139 - Biomolekule guanidinskog tipa u šećernoj bolesti (Vučić Lovrenčić, Marijana, MZOS ) ( CroRIS)
Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac